Lixte Biotechnology Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 33.35% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.3%	Legal & General Investment Management Limited	231,034	US$475.9k	0%	no data
4.42%	HighTower Advisors, LLC	99,432	US$204.8k	0%	no data
3.18%	FNY Investment Advisers, LLC	71,638	US$147.6k	42.5%	0.06%
2.26%	Jane Riggs	50,917	US$104.9k	0%	no data
2.26%	Arthur Riggs	50,917	US$104.9k	0%	no data
2.08%	Eric Forman	46,785	US$96.4k	0%	no data
1.11%	René Bernards	25,000	US$51.5k	0%	no data
1.1%	Ethos Financial Group, LLC	24,808	US$51.1k	0%	0.01%
0.76%	Geode Capital Management, LLC	17,161	US$35.4k	69.6%	no data
0.75%	Invesco Capital Management LLC	16,831	US$34.7k	0%	no data
0.64%	Schwartzberg Trust	14,286	US$29.4k	0%	no data
0.63%	Glenn Krinsky	14,166	US$29.2k	0%	no data
0.48%	Bastiaan van der Baan	10,730	US$22.1k	-2.45%	no data
0.4%	Daniel Sterling Trust	9,000	US$18.5k	0%	no data
0.4%	Savannah Sterling Trust	9,000	US$18.5k	0%	no data
0.4%	Charles Sterling Trust	9,000	US$18.5k	0%	no data
0.4%	Amanda Sterling Trust	9,000	US$18.5k	0%	no data
0.39%	Cole Forman	8,708	US$17.9k	0%	no data
0.37%	abrdn plc	8,392	US$17.3k	0%	no data
0.33%	Stephan Forman	7,480	US$15.4k	0%	no data
0.23%	Yun Yen	5,263	US$10.8k	0%	no data
0.23%	The Vanguard Group, Inc.	5,209	US$10.7k	0%	no data
0.094%	Tower Research Capital Europe Limited	2,110	US$4.3k	-34.4%	no data
0.089%	Kba Consulting Management Limited	2,000	US$4.1k	0%	0.01%
0.056%	Johannes Henricus Schellens	1,250	US$2.6k	0%	no data